Jejunoileal bypass changes the duodenal cholecystokinin and somatostatin cell density.
BACKGROUND
In obese patients, jejunoileal bypass (JIB) has been used to induce weight reduction. Changes in the neuroendocrine system may be affected by the JIB-operation, because the proximal small intestinal mucosa has a rich supply of endocrine cells and peptidergic nerves.


METHODS
In 37 obese patients operated with JIB 1-30 years ago, small intestinal biopsies were taken at the duodeno-jejunal flexure, proximal to the anastomosis and from 5 unoperated obese persons and 20 normal weight patients. The tissue specimens were processed for immunocytochemical demonstration of cells/nerves containing: gastrin, cholecystokinin (CCK), secretin, gastric inhibitory peptide (GIP), motilin, somatostatin, serotonin, glicentine, peptide YY (PYY), neurotensin, vasoactive intestinal peptide (VIP), substance P, neuropeptide Y (NPY) and galanin. The number of different endocrine cell-types were counted per unit length of mucosa, and the density of the peptidergic nerves was assessed semiquantitatively according to a schematic scale.


RESULTS
JIB-patients had an increased density of CCK and somatostatin cells in the duodenal mucosa. The CCK cells displayed a changed reaction pattern, with a greater cell number reacting with an antiserum directed towards a non-amidated mid-sequence of procholecystokinin compared with the other groups. In obese unoperated patients, the density of PYY and secretin cells was decreased compared with the JIB-patients and the density of the GIP cells compared with both other groups.


CONCLUSIONS
JIB induces an up-regulation of somatostatin and CCK precursor-containing cells in the duodenal mucosa. The time duration after the JIB did not seem to influence the results.
Ockander
Leif
L
Department of Internal Medicine, Ryhov's Hospital, Jönköping, Sweden.
Hedenbro
Jan L
JL
Rehfeld
Jens F
JF
Sjölund
Kristina
K
D000293:Adolescent; D000328:Adult; D000368:Aged; D002452:Cell Count; D002766:Cholecystokinin / Q000032:analysis* / Q000378:metabolism; D004386:Duodenum / Q000378:metabolism / Q000473:pathology*; D019858:Enteroendocrine Cells / Q000378:metabolism / Q000473:pathology*; D005260:Female; D005500:Follow-Up Studies; D005755:Gastrins / Q000032:analysis / Q000378:metabolism; D006728:Hormones / Q000032:analysis* / Q000378:metabolism; D006801:Humans; D007581:Jejunoileal Bypass / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D009765:Obesity / Q000473:pathology* / Q000601:surgery*; D013004:Somatostatin / Q000032:analysis* / Q000378:metabolism; D019864:Somatostatin-Secreting Cells / Q000378:metabolism / Q000473:pathology; D013997:Time Factors
D005755:Gastrins; D006728:Hormones; D013004:Somatostatin; D002766:Cholecystokinin